Taiwan FDA registration 4b98bbeb1f9be1d1cc6eed9b13ad7999
"Serpso" red blood cell preservation dilution
TW: “塞爾普索”紅血球保存稀釋液
Taiwan·Risk Class 1·CSL LIMITED·Registered Nov 05, 2010 – Nov 05, 2015CancelledRegistration details
- Analysis ID
- 4b98bbeb1f9be1d1cc6eed9b13ad7999
- Customs Code
- DHA04400947303
Company information
- Manufacturer
- CSL LIMITED
- Manufacturer Country
- Australia
- Authorized Representative
- GIRAFFES PHARMACEUTICAL COMPANY LTD.
Product details
- Intended Use
- Limited to the first level identification range of blood cell thinners (B.8200) of the management methods for medical devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.8200 Hemocytodilant
- Import Information
- import
Dates and status
- Registration Date
- Nov 05, 2010
- Expiry Date
- Nov 05, 2015
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for "Serpso" red blood cell preservation dilution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 4b98bbeb1f9be1d1cc6eed9b13ad7999 and manufactured by CSL LIMITED. The authorized representative in Taiwan is GIRAFFES PHARMACEUTICAL COMPANY LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices